<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-111837</identifier>
<setSpec>0001-6640</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Neuroleptic malignant syndrome and adverse reaction to oxcarbazepine in a pediatric patient</dc:title>
<dc:description xml:lang="en">Since the prescription of antipsychotic or neuroleptic medications are becoming more common in the pediatric population under polytherapy with neurological disorders is interesting to take into account this rare and potentially serious neuroleptic malignant syndrome and other possible adverse reactions to drugs. We describe a pediatric patient who developed neuroleptic malignant syndrome secondary to haloperidol/risperidone and a possible adverse reaction to oxcarbazepine(AU)</dc:description>
<dc:creator>Madurga Revilla, P</dc:creator>
<dc:creator>Peña Segura, J. L</dc:creator>
<dc:creator>Palanca Arias, D</dc:creator>
<dc:creator>García Iñiguez, J. P</dc:creator>
<dc:creator>Gómez Cámara, O</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Puesto que la prescripción de antipsicóticos o neurolépticos está siendo cada vez más frecuente en la población pediátrica con trastornos neurológicos en politerapia, es interesante tener presente un cuadro tan infrecuente y potencialmente grave como el síndrome neuroléptico maligno, así como otras posibles reacciones adversas a medicamentos. Describimos el caso de un paciente pediátrico que desarrolló un síndrome neuroléptico maligno secundario a haloperidol y/o risperidona, al que pudo sumarse una reacción adversa medicamentosa a oxcarbazepina, con una evolución favorable(AU)</dc:description>
<dc:source>Acta Pediatr Esp;71(4): 111-111[e73-e76], abr. 2013.</dc:source>
<dc:identifier>ibc-111837</dc:identifier>
<dc:title xml:lang="es">Síndrome neuroléptico maligno y reacción a oxcarbazepina en un paciente pediátrico</dc:title>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d14542^s22073</dc:subject>
<dc:subject>^d5175^s22012</dc:subject>
<dc:subject>^d12617^s22012</dc:subject>
<dc:subject>^d14542^s22020</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d12617^s22057</dc:subject>
<dc:subject>^d12617^s22016</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d5444^s22012</dc:subject>
<dc:subject>^d9650^s22057</dc:subject>
<dc:subject>^d9650^s22012</dc:subject>
<dc:subject>^d3639^s22020</dc:subject>
<dc:subject>^d5444^s22027</dc:subject>
<dc:subject>^d3639^s22000</dc:subject>
<dc:type>article</dc:type>
<dc:date>201304</dc:date>
</metadata>
</record>
</ibecs-document>
